Lv1
40 积分 2025-09-22 加入
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4
4个月前
已完结
A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia
4个月前
已完结
New finding based on Comparative Toxicogenomics Database: Hepatic YY1 mediates drug-induced liver injury
4个月前
已完结
皖公网安备34019202002308
